These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24550541)

  • 1. Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.
    Farren MR; Carlson LM; Netherby CS; Lindner I; Li PK; Gabrilovich DI; Abrams SI; Lee KP
    Sci Signal; 2014 Feb; 7(313):ra16. PubMed ID: 24550541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
    J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells.
    Hix LM; Karavitis J; Khan MW; Shi YH; Khazaie K; Zhang M
    J Biol Chem; 2013 Apr; 288(17):11676-88. PubMed ID: 23486482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.
    Nefedova Y; Huang M; Kusmartsev S; Bhattacharya R; Cheng P; Salup R; Jove R; Gabrilovich D
    J Immunol; 2004 Jan; 172(1):464-74. PubMed ID: 14688356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
    Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
    J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma.
    Alshamsan A
    Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):465-9. PubMed ID: 21999714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway.
    Nefedova Y; Nagaraj S; Rosenbauer A; Muro-Cacho C; Sebti SM; Gabrilovich DI
    Cancer Res; 2005 Oct; 65(20):9525-35. PubMed ID: 16230418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells.
    Yi Z; Li L; Matsushima GK; Earp HS; Wang B; Tisch R
    Blood; 2009 Oct; 114(15):3191-8. PubMed ID: 19667404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
    Tkach M; Coria L; Rosemblit C; Rivas MA; Proietti CJ; Díaz Flaqué MC; Beguelin W; Frahm I; Charreau EH; Cassataro J; Elizalde PV; Schillaci R
    J Immunol; 2012 Aug; 189(3):1162-72. PubMed ID: 22753933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
    Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I
    Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression.
    Farren MR; Carlson LM; Lee KP
    Immunol Res; 2010 Mar; 46(1-3):165-76. PubMed ID: 19756409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptor regulates mouse GM-CSF-derived dendritic cell differentiation in vitro.
    Zhong L; Yang Q; Xie W; Zhou J
    Mol Immunol; 2014 Jul; 60(1):32-43. PubMed ID: 24747959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
    Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
    J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway.
    van Pul KM; Vuylsteke RJCLM; de Beijer MTA; van de Ven R; van den Tol MP; Stockmann HBAC; de Gruijl TD
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.
    Che KF; Shankar EM; Muthu S; Zandi S; Sigvardsson M; Hinkula J; Messmer D; Larsson M
    Mol Med; 2012 Oct; 18(1):1169-82. PubMed ID: 22777388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis.
    Rottenberg ME; Carow B
    Semin Immunol; 2014 Dec; 26(6):518-32. PubMed ID: 25458989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
    Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
    Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration.
    Snyder M; Huang XY; Zhang JJ
    J Biol Chem; 2011 Nov; 286(45):38886-93. PubMed ID: 21937440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
    Okada S; Han S; Patel ES; Yang LJ; Chang LJ
    Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.
    Liu Q; Tan Q; Zheng Y; Chen K; Qian C; Li N; Wang Q; Cao X
    J Biol Chem; 2014 Apr; 289(16):11522-11535. PubMed ID: 24627480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.